Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-27Clinical Trial Update: Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis [Phase 2, Phase 3]
A Phase 2/3 trial evaluating rifaximin for bloating in cystic fibrosis patients has been withdrawn. The document records the withdrawal of t…
-
CLINICAL_TRIALS withdrawal · 2025-05-29Clinical Trial Update: Hyperpolarized Xenon Imaging in Patients With Cystic Fibrosis
Clinical trial investigating hyperpolarized xenon imaging in patients with cystic fibrosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: ActivOnline: Physical Activity in Cystic Fibrosis Trial UK [NA]
A clinical trial investigating ActivOnline for physical activity in cystic fibrosis has been withdrawn in the UK.
-
CLINICAL_TRIALS withdrawal · 2022-06-30Clinical Trial Update: A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis [Phase 2, Phase 3]
A dose-finding study of inhaled OligoG vs placebo in cystic fibrosis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-01-14Clinical Trial Update: Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis [Phase 4]
Phase 4 trial on epidemiology and treatment of small-colony variant Staphylococcus aureus in cystic fibrosis was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2019-03-29EMA Withdrawn: Vantobra (tobramycin) — Pari Pharma GmbH
EMA has withdrawn Vantobra (tobramycin) from the market.
-
CLINICAL_TRIALS withdrawal · 2019-01-10Clinical Trial Update: Growth Hormone Treatment Study in Children With Cystic Fibrosis [Phase 2, Phase 3]
A growth hormone treatment trial in children with cystic fibrosis was withdrawn after Phase 2/3 enrollment.
-
CLINICAL_TRIALS withdrawal · 2018-07-31Clinical Trial Update: Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa [Phase 3]
A Phase 3 study evaluating Arikace for chronic Pseudomonas aeruginosa infection in Cystic Fibrosis patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
A Penn State University–sponsored trial investigating the association between Helicobacter pylori infection and abdominal pain in cystic fib…
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: Pulmozyme in Cystic Fibrosis With Sinusitis [Phase 3]
Phase 3 trial of Pulmozyme for cystic fibrosis with sinusitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-08Clinical Trial Update: Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis
A clinical trial evaluating intermittent versus continuous infusion of meropenem in cystic fibrosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-21Clinical Trial Update: Zoledronic Acid in Cystic Fibrosis [Phase 4]
A Phase 4 clinical trial evaluating zoledronic acid for cystic fibrosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-09Clinical Trial Update: A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF) [Phase 1]
Gilead Sciences has withdrawn its Phase 1 trial of GS-9411 in cystic fibrosis patients, which was evaluating safety, tolerability, and pharm…
-
CLINICAL_TRIALS withdrawal · 2015-06-11Clinical Trial Update: Effect of Topical and Systemic Decolonization of Staphylococcus Aureus (SA) in Pediatric Cystic Fibrosis (CF) Patients [NA]
A clinical trial evaluating topical and systemic decolonization of Staphylococcus aureus in pediatric cystic fibrosis patients was withdrawn…
-
CLINICAL_TRIALS withdrawal · 2015-03-18Clinical Trial Update: Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of Life
The clinical trial evaluating the respiratory microbiota in infants with cystic fibrosis during the first year of life has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-01-15Clinical Trial Update: Long Term Significance (Survival) of LCI in Patients With Cystic Fibrosis
This clinical trial update indicates a study evaluating the long-term significance of Lung Clearance Index (LCI) in cystic fibrosis patients…
-
CLINICAL_TRIALS withdrawal · 2014-01-30Clinical Trial Update: Statins To Treat Adult Cystic Fibrosis [Phase 1, Phase 2]
A Phase 1/2 trial investigating statin therapy for adults with cystic fibrosis and systemic inflammation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-11Clinical Trial Update: Sildenafil Trial in Children and Young Adults With CF [Phase 1, Phase 2]
Phase 1/2 trial of sildenafil in children and young adults with cystic fibrosis and mild-to-moderate lung disease was withdrawn. The study s…
-
CLINICAL_TRIALS withdrawal · 2010-05-13Clinical Trial Update: Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients [NA]
The open-label safety study of DCI-1020 in pediatric cystic fibrosis patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-02-22Clinical Trial Update: Vitamin D3 for the Treatment of Low Vitamin D in Cystic Fibrosis [Phase 3]
A Phase 3 trial evaluating Vitamin D3 for treating vitamin D deficiency in cystic fibrosis patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2009-05-06Clinical Trial Update: Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis [Phase 2]
A phase 2 trial evaluating AZD1236 for cystic fibrosis was withdrawn.